A compound of formula (I), or a pharmaceutically acceptable salt and/or solvate (including hydrate) thereof; and the use of a compound of formula (I) in the treatment of a TNF-mediated disease, disorder, or condition, or a p38-mediated disease, disorder, or condition, in particular the allergic and non-allergic airways diseases, more particularly obstructive or inflammatory airways diseases, preferably chronic obstructive pulmonary disease.

 
Web www.patentalert.com

< Methods for modulating lipoprotein and cholesterol levels in humans

< Carboxylic acid derivatives as IP antagonists

> 1,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

> Remedies for neurodegenerative diseases

~ 00239